Focus on therapeutic peptides and their delivery

Area of Science:

• Biochemistry and Pharmacology
• Drug Delivery Systems

Background:

• Peptides are versatile therapeutic agents bridging small molecules and large biologics.
• They offer enhanced specificity, safety, and tissue penetration with simpler manufacturing.
• The global peptide therapeutics market is rapidly expanding, with numerous approvals in recent years.

Purpose of the Study:

• To compare major parenteral administration routes (subcutaneous and intravenous) for therapeutic peptides.
• To analyze the impact of these routes on pharmacokinetic profiles and patient outcomes.
• To explore innovative drug delivery systems addressing peptide stability, bioavailability, and efficacy challenges.

Main Methods:

• Comparative analysis of subcutaneous and intravenous administration for therapeutic peptides.
• Review of pharmacokinetic data and patient outcomes associated with different administration routes.
• Exploration of novel drug delivery technologies for peptide therapeutics.

Main Results:

• Parenteral administration routes significantly influence peptide pharmacokinetic profiles and therapeutic effectiveness.
• Each route presents distinct advantages and limitations impacting clinical application.
• Innovative delivery systems show promise in overcoming challenges related to peptide stability and bioavailability.

Conclusions:

• Optimizing peptide administration routes and delivery systems is crucial for maximizing therapeutic benefits.
• Further research into advanced formulations can enhance the clinical utility of peptide-based drugs.
• Peptide therapeutics represent a growing and important area in modern medicine.